Header Logo

Connection

WILLIAM PEACOCK to Biomarkers

Back to Details
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Biomarkers.
WILLIAM PEACOCK
Connection Strength
3.926
Biomarkers
  1. On-Field Rule Out of Mild Traumatic Brain Injury: Can Blood-Based Biomarker Testing Change Outcome of Major Sporting Events? J Appl Lab Med. 2024 Sep 03; 9(5):1057-1063.
    View in: PubMed
    Score: 0.481
  2. Where Are the Stroke Markers? Clin Chem. 2017 01; 63(1):252-254.
    View in: PubMed
    Score: 0.278
  3. Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department. Acute Card Care. 2009; 11(3):138-45.
    View in: PubMed
    Score: 0.162
  4. Predictive value of neutrophil gelatinase-associated lipocalin (NGAL) values for cardiac arrest outcomes: A systematic review and meta-analysis. Am J Emerg Med. 2024 06; 80:221-223.
    View in: PubMed
    Score: 0.117
  5. Methods of the PivotaL triAl of the Atellica VTLi point of care emergencY dePartment high sensitivity troponin evalUationS. Clin Biochem. 2023 Nov; 121-122:110679.
    View in: PubMed
    Score: 0.113
  6. Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis. Ann Intern Med. 2022 01; 175(1):101-113.
    View in: PubMed
    Score: 0.099
  7. Using Sex-specific Cutoffs for High-sensitivity Cardiac Troponin T to Diagnose Acute Myocardial Infarction. Acad Emerg Med. 2021 04; 28(4):463-466.
    View in: PubMed
    Score: 0.091
  8. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation. 2020 10 20; 142(16):1532-1544.
    View in: PubMed
    Score: 0.091
  9. Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. Am J Emerg Med. 2021 08; 46:170-175.
    View in: PubMed
    Score: 0.090
  10. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation. Acad Emerg Med. 2020 08; 27(8):671-680.
    View in: PubMed
    Score: 0.088
  11. Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain. Clin Chem. 2019 02; 65(2):302-312.
    View in: PubMed
    Score: 0.081
  12. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome. JAMA Cardiol. 2018 02 01; 3(2):104-111.
    View in: PubMed
    Score: 0.076
  13. High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain. Clin Chem. 2017 Nov; 63(11):1724-1733.
    View in: PubMed
    Score: 0.074
  14. Controls Can't Be Ignored. J Neurotrauma. 2017 04 15; 34(8):1710.
    View in: PubMed
    Score: 0.070
  15. Can a Point-of-Care Troponin I Assay be as Good as a Central Laboratory Assay? A MIDAS Investigation. Ann Lab Med. 2016 Sep; 36(5):405-12.
    View in: PubMed
    Score: 0.069
  16. Considerations for initial therapy in the treatment of acute heart failure. Crit Care. 2015 Nov 10; 19:399.
    View in: PubMed
    Score: 0.065
  17. Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH. Eur J Heart Fail. 2015 Dec; 17(12):1271-82.
    View in: PubMed
    Score: 0.065
  18. Emergency department use of galectin-3. Crit Pathw Cardiol. 2014 Jun; 13(2):73-7.
    View in: PubMed
    Score: 0.059
  19. Procalcitonin as a biomarker for early sepsis in the emergency department. Eur J Emerg Med. 2014 Apr; 21(2):112-7.
    View in: PubMed
    Score: 0.058
  20. Using galectin-3 to reduce heart failure rehospitalization. Future Cardiol. 2014 Mar; 10(2):221-7.
    View in: PubMed
    Score: 0.058
  21. Neutrophil gelatinase associated lipocalin in acute kidney injury. Postgrad Med. 2013 Nov; 125(6):82-93.
    View in: PubMed
    Score: 0.057
  22. ST2 in emergency department patients with noncardiac dyspnea. Acad Emerg Med. 2013 Nov; 20(11):1207-10.
    View in: PubMed
    Score: 0.057
  23. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013 Jul 09; 62(2):150-160.
    View in: PubMed
    Score: 0.055
  24. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013 Oct 03; 168(3):2186-94.
    View in: PubMed
    Score: 0.054
  25. Central versus local adjudication of myocardial infarction in a cardiac biomarker trial. Am Heart J. 2013 Mar; 165(3):273-279.e1.
    View in: PubMed
    Score: 0.054
  26. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
    View in: PubMed
    Score: 0.049
  27. Primary role of B-type natriuretic peptide across the clinical spectrum: from emergency medicine to transitional care and beyond into the community. Congest Heart Fail. 2011 Jan-Feb; 17(1):8-13.
    View in: PubMed
    Score: 0.047
  28. Hemodynamic changes as a diagnostic tool in acute heart failure--a pilot study. Am J Emerg Med. 2012 Jan; 30(1):174-80.
    View in: PubMed
    Score: 0.046
  29. Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers. Rev Cardiovasc Med. 2010; 11 Suppl 2:S3-12.
    View in: PubMed
    Score: 0.044
  30. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008 Sep; 10(9):824-39.
    View in: PubMed
    Score: 0.040
  31. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26.
    View in: PubMed
    Score: 0.039
  32. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
    View in: PubMed
    Score: 0.036
  33. Analytical Characterization and Validation of a Novel Automated Amino-Terminal proB-Type Natriuretic Peptide Assay. J Appl Lab Med. 2025 May 02; 10(3):659-670.
    View in: PubMed
    Score: 0.031
  34. Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in acute coronary syndrome patients: A systematic review and meta-analysis. Kardiol Pol. 2025; 83(1):52-61.
    View in: PubMed
    Score: 0.030
  35. Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiative. BMJ Open. 2024 06 13; 14(6):e083752.
    View in: PubMed
    Score: 0.030
  36. Diagnostic and prognostic performance of the neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients. Kardiol Pol. 2024; 82(3):276-284.
    View in: PubMed
    Score: 0.029
  37. Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines. Eur Heart J Acute Cardiovasc Care. 2024 Feb 09; 13(1):15-23.
    View in: PubMed
    Score: 0.029
  38. Navigating the Observation Zone: Do Risk Scores Help Stratify Patients With Indeterminate High-Sensitivity Cardiac Troponins? Circulation. 2024 01 02; 149(1):70-72.
    View in: PubMed
    Score: 0.029
  39. Retrospective review: the incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail. 2003 Nov-Dec; 9(6):303-8.
    View in: PubMed
    Score: 0.028
  40. Integrated Bioinformatics Analysis Confirms the Diagnostic Value of Nourin-Dependent miR-137 and miR-106b in Unstable Angina Patients. Int J Mol Sci. 2023 Sep 30; 24(19).
    View in: PubMed
    Score: 0.028
  41. Concentration of hs-Troponin in small cohort of transgender patients. Clin Chim Acta. 2023 Jan 15; 539:66-69.
    View in: PubMed
    Score: 0.027
  42. Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. Coron Artery Dis. 2022 08 01; 33(5):376-384.
    View in: PubMed
    Score: 0.025
  43. The B-type natriuretic peptide assay: a rapid test for heart failure. Cleve Clin J Med. 2002 Mar; 69(3):243-51.
    View in: PubMed
    Score: 0.025
  44. Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study. J Card Fail. 2022 02; 28(2):226-233.
    View in: PubMed
    Score: 0.025
  45. Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction. Am J Emerg Med. 2022 06; 56:323-324.
    View in: PubMed
    Score: 0.024
  46. Outpatient versus observation/inpatient management of emergency department patients rapidly ruled-out for acute myocardial infarction: Findings from the HIGH-US study. Am Heart J. 2021 01; 231:6-17.
    View in: PubMed
    Score: 0.023
  47. Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection? Clin Chem. 2020 09 01; 66(9):1146-1149.
    View in: PubMed
    Score: 0.023
  48. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. Stroke. 2020 08; 51(8):2386-2394.
    View in: PubMed
    Score: 0.023
  49. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 05; 8(5):415-422.
    View in: PubMed
    Score: 0.022
  50. Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 2000 Mar; 35(3):213-20.
    View in: PubMed
    Score: 0.022
  51. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study. Ann Emerg Med. 2020 07; 76(1):1-13.
    View in: PubMed
    Score: 0.022
  52. Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failure. Int J Cardiol. 2020 02 01; 300:245-251.
    View in: PubMed
    Score: 0.022
  53. Pivotal findings for a high-sensitivity cardiac troponin assay: Results of the HIGH-US study. Clin Biochem. 2020 Apr; 78:32-39.
    View in: PubMed
    Score: 0.021
  54. sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure. Acta Cardiol. 2020 Dec; 75(8):739-747.
    View in: PubMed
    Score: 0.021
  55. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The?ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.019
  56. Prohormones in the Early Diagnosis of Cardiac Syncope. J Am Heart Assoc. 2017 12 14; 6(12).
    View in: PubMed
    Score: 0.019
  57. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2018 01 23; 137(4):354-363.
    View in: PubMed
    Score: 0.019
  58. Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
    View in: PubMed
    Score: 0.019
  59. Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. N Engl J Med. 2017 05 18; 376(20):1956-1964.
    View in: PubMed
    Score: 0.018
  60. Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction. Am J Nephrol. 2017; 45(4):304-309.
    View in: PubMed
    Score: 0.018
  61. Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality. Acad Emerg Med. 2016 11; 23(11):1267-1273.
    View in: PubMed
    Score: 0.017
  62. Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. Medicine (Baltimore). 2016 Nov; 95(46):e4965.
    View in: PubMed
    Score: 0.017
  63. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017 Feb; 35(2):274-280.
    View in: PubMed
    Score: 0.017
  64. Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study. BMJ Open. 2016 Feb 25; 6(2):e009746.
    View in: PubMed
    Score: 0.017
  65. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial. JACC Cardiovasc Imaging. 2015 Nov; 8(11):1272-1281.
    View in: PubMed
    Score: 0.016
  66. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial. Emerg Med J. 2016 Jan; 33(1):23-9.
    View in: PubMed
    Score: 0.016
  67. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63.
    View in: PubMed
    Score: 0.016
  68. Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trial. Am Heart J. 2015 Apr; 169(4):572-8.e1.
    View in: PubMed
    Score: 0.015
  69. Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med. 2015 Jan; 22(1):94-112.
    View in: PubMed
    Score: 0.015
  70. Galectin-3: a modifiable risk factor in heart failure. Cardiovasc Drugs Ther. 2014 Jun; 28(3):237-46.
    View in: PubMed
    Score: 0.015
  71. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). JACC Heart Fail. 2013 Jun; 1(3):192-9.
    View in: PubMed
    Score: 0.014
  72. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial. Emerg Med J. 2013 Aug; 30(8):633-7.
    View in: PubMed
    Score: 0.013
  73. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012 Jun 05; 59(23):2091-8.
    View in: PubMed
    Score: 0.013
  74. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail. 2012 Jan; 14(1):22-31.
    View in: PubMed
    Score: 0.012
  75. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011 Mar 26; 377(9771):1077-84.
    View in: PubMed
    Score: 0.012
  76. Placental growth factor and B-type natriuretic peptide as independent predictors of risk from a multibiomarker panel in suspected acute coronary syndrome (Acute Risk and Related Outcomes Assessed With Cardiac Biomarkers [ARROW]) study. Am J Cardiol. 2011 Mar 15; 107(6):821-6.
    View in: PubMed
    Score: 0.012
  77. Japanese-Western consensus meeting on biomarkers. Int Heart J. 2011; 52(5):253-65.
    View in: PubMed
    Score: 0.012
  78. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail. 2011 Jan; 13(1):37-42.
    View in: PubMed
    Score: 0.012
  79. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010 May 11; 55(19):2062-76.
    View in: PubMed
    Score: 0.011
  80. Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011 Feb; 29(2):162-7.
    View in: PubMed
    Score: 0.011
  81. Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail. 2009 Nov; 11(11):1043-9.
    View in: PubMed
    Score: 0.011
  82. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol. 2008 Aug 12; 52(7):534-40.
    View in: PubMed
    Score: 0.010
  83. Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application? Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):46-8.
    View in: PubMed
    Score: 0.010
  84. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007 Aug 14; 50(7):607-13.
    View in: PubMed
    Score: 0.009
  85. The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting. Ann Emerg Med. 2007 Feb; 49(2):145-52, 152.e1.
    View in: PubMed
    Score: 0.009
  86. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med. 2006 Dec; 48(6):666-77, 677.e1-9.
    View in: PubMed
    Score: 0.009
  87. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Ann Emerg Med. 2006 Dec; 48(6):660-5.
    View in: PubMed
    Score: 0.009
  88. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006 Jan 17; 47(2):312-8.
    View in: PubMed
    Score: 0.008
  89. A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. Am Heart J. 2003 Dec; 146(6):993-8.
    View in: PubMed
    Score: 0.007
  90. Troponin T in elders with suspected acute coronary syndromes. Am J Emerg Med. 2003 Jul; 21(4):293-7.
    View in: PubMed
    Score: 0.007
  91. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol. 2002 Dec 18; 40(12):2065-71.
    View in: PubMed
    Score: 0.007
  92. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol. 2000 Feb 15; 85(4):421-6.
    View in: PubMed
    Score: 0.005
  93. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol. 1999 Feb; 33(2):471-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.